Chronic kidney disease : signs/symptoms, management options and potential complications /
Chronic kidney disease is a non-communicable disease that has experienced a global surge in incidence and prevalence over the past few decades, and it has been increasingly considered a major contributor to the global disease burden and mortality. In prior years, most of the awareness and treatment...
Saved in:
| Other Authors: | , , |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
New York :
Nova Science Publishers,
[2014]
|
| Series: | Nephrology research and clinical developments series.
|
| Subjects: | |
| Online Access: | CONNECT |
Table of Contents:
- CHRONIC KIDNEY DISEASE SIGNS/SYMPTOMS, MANAGEMENT OPTIONS AND POTENTIAL COMPLICATIONS; CHRONIC KIDNEY DISEASE SIGNS/SYMPTOMS, MANAGEMENT OPTIONS AND POTENTIAL COMPLICATIONS; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Section A: Chronic Kidney Disease in the General Population; Chapter I Signs and Symptoms of Chronic Kidney Disease; Abstract; 1. Introduction; 2. Definition; 3. Symptoms of CKD; 3.1. General Symptoms; 3.1.1. Anorexia; 3.1.2. Cachexia; 3.1.3. Malaise; 3.2. Cardiovascular; 3.3. Pulmonary; 3.4. Gastrointestinal; 3.5. Genitourinary; 3.6. Hematological.
- 3.7. Neurological3.7.1. Restless Leg Syndrome (RLS) and Periodic Limb Movement (PLM) disorder; 3.8. Skin; 3.9. Psychiatric; 4. Signs of CKD; References; Chapter II Complications of Chronic Kidney Disease; Abstract; 1. Anemia; Pathogenesis; i. Erythropoietin Deficiency; ii. Iron Deficiency; iii. Hepcidin; iv. Chronic Inflammation, Infections and Oxidative stress; v. Secondary Hyperparathyroidism; Incidence and Prevalence; Diagnosis; 2. Blood and Immune Disorders in Chronic Kidney Disease; 2.1. Bleeding Diathesis in Uremia; Pathogenesis; Clinical Manifestations; Diagnosis.
- 2.2. Heparin Induced ThrombocytopeniaIncidence; Pathogenesis; Clinical Manifestations; Diagnosis; 2.3. Thrombotic Events; 2.4. Immune Dysfunction in Uremia; 3. Cardiovascular Disease; Epidemiology; Risk Factors; i. Conventional Risk Factors; ia. Hypertension; ib. Diabetes Mellitus; ic. Dyslipidemia; id. Insulin Resistance; ie. Smoking; ii. Non-conventional Risk Factors; iia. Anemia; iib. Oxidative stress; iic. Inflammation; iid. Hyperhomocysteinemia and endothelial dysfunction; iie. Advanced Glycation End Products; iii. Other Risk Factors; Clinical Manifestations; Diagnosis.
- 4. Bone and Mineral Metabolism in CKDPathogenesis; a. High Turnover Bone Disease; Abnormalities of Calcium Homeostasis; Abnormalities in Phosphate Homeostasis; Abnormalities of Vitamin D Homeostasis; Clinical Manifestations of High Turnover Bone Disease; b. Low Turnover Bone Disease; Diagnosis of Renal Bone Disease; 5. Acid Base Disturbances in CKD; Pathogenesis; Uremic Acidosis and Nutritional status; Uremic Acidosis and Renal Osteodystrophy; Uremic Acidosis and Cardiovascular Disease; 6. Neuropsychological Manifestations in Chronic Kidney Disease; 6.1. Uremic Encephalopathy; Pathogenesis.
- Clinical ManifestationsDiagnosis; 6.2. Peripheral Neuropathy; Mononeuropathy; Polyneuropathy; 6.3. Autonomic Neuropathy; 6.4. Neurologic Syndromes Associated with Renal Replacement Therapy; Dialysis Disequilibrium Syndrome; Dialysis Encephalopathy; Restless Leg Syndrome; 6.5. Sleep Disorders; Sleep Disordered Breathing (SDB) and Obstructive Sleep Apnea (OSA); Excessive Daytime Sleepiness (EDS); 6.6. Psychological Manifestations; References; Chapter III Treatment of Chronic Kidney Disease Complications; Abstract; I. Anemia; Historical Background; Erythropoiesis Stimulating Agents (ESAs).
